Skip to main content
Log in

Aspirin fails in women at risk of pre-eclampsia

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Results of a major trial have dashed hopes that low-dose aspirin has a role for all pregnant women at increased risk of pre-eclampsia or intrauterine growth retardation. The Collaborative Low-dose Aspirin Study in Pregnancy (CLASP) has refuted the results of smaller trials of low-dose aspirin and other antiplatelet therapies that suggested pre-eclampsia could be reduced by about 75% with these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Short, R. Aspirin fails in women at risk of pre-eclampsia. Inpharma Wkly. 929, 3 (1994). https://doi.org/10.2165/00128413-199409290-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199409290-00002

Keywords

Navigation